艾滋病抗体治疗的研究现状与展望
被引量：1
Current Status and Prospect of Antibody Therapy in AIDS
摘要
艾滋病的发病机制非常复杂 ,到目前为止还没有根治该病的特效药物或疫苗 ,但在实验中发现许多基因工程抗体具有阻断病毒入侵、中和病毒活性和抑制病毒复制作用 。
出处
《中国皮肤性病学杂志》
CAS
北大核心
2003年第6期408-409,共2页
The Chinese Journal of Dermatovenereology
参考文献16
-
1[1]Steinberger P,Andris-Widhopf J,Buhler B,et al. Functional deletion of the CCR5 receptor by intracellular immunization produces cells that are refractory to CCR5-dependent HIV-1 infection and cell fusion[J].Proc Natl Acad Sci, 2000, 97 (2): 805 -810.
-
2[2]Major JG, Liou RS, Sun LK, et al. Construction and characterization of chimeric and humanized forms of a broadly neutralizing monoclonal antibody to HIV- 1 [ J ]. Hum Antibodies Hybridomas, 1994,5: 9 - 17.
-
3[3]Mascola JR, Stiegler G, VanCott TC, et al.Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies[ J ]. Nat. Med, 2000,6:207-210.
-
4[4]Lewis AD, Chen R, Montefiori DC, et al.Generation of neutralizing activity against human immunodeficiency virus type 1 in serum by antibody gene transfer[J]. J Virol,2002,76(17) :8769 - 8775.
-
5[5]Zwick MB, Labrijn AF, Wang M, et al.Broadly neutralizing antibodies targeted to the membrane-proximal external region of human immunodeficiency virus type 1 glycoprotein gp41 [J]. J Virol, 2001,75:10892- 10905.
-
6[6]Stiegler G, Kunert R, Purtscher M, et al. A potent cross-clade neutralizing human monoclonal antibody against a novel epitope on gp41 of human immunodeficiency virus type 1 [ J ]. AIDS Res Hum Retroviruses, 2001,17(18):1757-1765.
-
7[7]Frankel SS, Steinman Rm, Michael NL, et al. Neutralizing monoclonal antibodies block human immunodeficiency virus type 1 infection of dendritic cells and transmission to T cells[J]. J Virol, 1998,72(12): 9788 -9794.
-
8[8]Baba TW, Liska V, Hofmann-Lehmann R,et al. Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian-human immunodeficiency virus infection [ J ]. Nat Med, 2000,6: 200-206.
-
9[9]Regina HL,Josef V, Robert A, et al. Postnatal passive immunization of neonatal macaques with a triple combination of human monoclonal antibodies against oral simian-human immunodeficiency virus challenge [ J ]. Journal of Virology, 2001, 75(16) :7470 - 7480.
-
10[10]Pardridge WM,Bichel U, Buciak J, et al.Enhanced endocytosis and anti-human immunodeficiency virus type 1 activity of antirev antibodies after cationization [ J ]. J Infect Dis, 1994,169(1) :55 - 61.
同被引文献13
-
1刘志刚,董洪明.抗体治疗皮肤病的研究[J].现代医药卫生,2004,20(16):1620-1622. 被引量：1
-
2金海玉,王晓华,梁晚枫,杜凤林.羊抗犬瘟热异源单血清治疗犬瘟热的临床观察[J].吉林畜牧兽医,2005,27(12):60-61. 被引量：3
-
3彭如意,王捷.人源化治疗性单克隆抗体的研究进展[J].实用医学杂志,2007,23(5):753-754. 被引量：4
-
4Obeidat B S, Strickland J R, Vogt M L, et al. Effects of lo- coweed on serum swainsonine and selected serum constituents in sheep during acute and subacute oral/intraruminal exposure [J].J Anita Sci, 2005,83 : 466-477.
-
5Zhang J S, Liu Y X, Hu L X, et al. Preparation and charac- terization of SARS in-house reference anti serum [J]. Vaccine, 2005,23 : 5666-5669.
-
6Winkler T, Sharma H S, Gordh T, et al. Topical application ofdynorphin A (1 - 17) antiserum attenuates trauma induced al- terations in spinal cord evoked potentials, microvascular perme- ability disturbances, edema formation and cell injury [J]. Amino Acids, 2002, 23: 273-281.
-
7Wu H, Schwasinger E T, Hong J, et al. Pretreatment with an- tiserum against dynorphin, substance P, or cholecystokinin en- hances the morphine-produced anti-allodynia in the sciatic nerve ligated mice[J]. Neuroscience Letters, 2005,386: 46-51.
-
8Yang C J, Suo X, Huang X X, et al. Protection of mice a- gainst homologous or heterologous infections with antiserum mix- tare to the predominant variable antigen type repertoire of Try- panosoma evansi YNB stock [J], Experimental Parasitology, 2007, 116(1):53-58.
-
9Trebichavsky I, Vladimoir D, Zuzana R.Effect of peroral an- ti-bacterial antiserum treatment on intestinal immune parameters of germ-fxee piglets intragastrically infected with virulent Salmonella typhimurium or enteropathogenic E. coli [J]. Veteri-nary Immunology and Immunopathology, 1999, 67:55-65.
-
10杨海东,罗傲雪,范益军,秦之香.单克隆抗体在治疗肿瘤中的研究进展[J].时珍国医国药,2007,18(11):2685-2686. 被引量：2
-
1谢晨,郑邦德,郭振华.甘肃省部分高危人群艾滋病抗体的实验室检测[J].兰州医学院学报,1996,22(2):69-70.
-
2徐启桓,舒欣,陈禄彪,周元平,姚集鲁.E抗原和E抗体阳性的慢性乙型肝炎组织病理学研究[J].中华肝脏病杂志,2001,9(6):340-342. 被引量：17
-
3张鹏,王昭,赵江宁,鹿全意,牛小青.重组人白介素-11治疗特发性血小板减少性紫癜2例[J].临床血液学杂志,2007,20(1):53-54. 被引量：4
-
4抗病毒治疗可降低肝癌发生风险[J].中国家庭医生,2013(7):2-2.
-
5姚勤伟.抗-Tat抗体预示HIV感染的进程缓慢[J].传染病网络动态,2005(6):10-10.
-
6李荣军,徐春霞,王健,杨小丽,李焱,赵平,付丽,向洪志.苦参素注射液对慢性乙型肝炎患者治疗的临床研究[J].国际病毒学杂志,2015,22(5):319-322. 被引量：3
-
7丙型肝炎病毒可在口腔粘膜中复制[J].传染病网络动态,2001(7):5-5.
-
8陈新,罗永雄,万建中,曾真.拉米夫定联合安络化纤丸治疗慢性乙型肝炎肝硬化30例临床观察[J].传染病信息,2006,19(5):273-274. 被引量：1
-
9陈新,罗永雄,万建中,曾真.拉米夫定联合安络化纤丸治疗乙型肝炎肝硬化30例临床观察[J].实用肝脏病杂志,2007,10(2):118-119. 被引量：7
-
10严运兵.拉米夫定治疗慢性乙型肝炎35例疗效观察[J].实用肝脏病杂志,2005,8(4):226-227.
